Search Results

The Last 50 years of Hemophilia Care: A Golden Era.

• Authors : Seth, Tulika

Subjects: HEMOPHILIA; HEALTH facilities; BLOOD coagulation factor VIII antibodies

• Source: Indian Pediatrics; May2024, Vol. 61 Issue 5, p489-493, 5p

Record details

e‐Posters.

Subjects: ANTIPHOSPHOLIPID syndrome; VON Willebrand disease; POSITRON emission tomography computed tomography

• Source: British Journal of Haematology; Apr2024 Supplement 1, Vol. 204, p118-209, 92p

Record details

Evaluation of anti‐factor VIII antibodies in haemophilia A subjects switching products following a provincial tender.

• Authors : Dubé, Evemie¹ (AUTHOR); Merlen, Clémence¹ (AUTHOR); Bonnefoy, Arnaud¹ (AUTHOR)

Subjects: *BLOOD coagulation factor VIII antibodies; *HEMOPHILIA; *VON Willebrand disease

• Source: Haemophilia. Jan2022, Vol. 28 Issue 1, pe1-e4. 4p. 2 Charts.

Record details

Main Congress Oral Abstracts.

Subjects: VON Willebrand disease; HEALTH facilities; BLOOD coagulation factor VIII antibodies

• Source: Haemophilia; 2024 Suppl 1, Vol. 30, p18-27, 10p

Record details

Key Drivers of Coagulation Factor Use in Von Willebrand Disease During Hospitalization: An Overview of the French BERHLINGO Cohort.

• Authors : Horvais, Valérie; Beurrier, Philippe; Cussac, Vincent

Subjects: VON Willebrand disease; BLOOD coagulation factor VIII; BLOOD coagulation factors

• Source: Clinical Drug Investigation; Jan2024, Vol. 44 Issue 1, p35-49, 15p

Record details

In vitro field study and worldwide survey assessing how clinical haemostasis laboratories analyse recombinant and plasma‐derived von Willebrand factor products.

• Authors : Turecek, Peter L.; Ilk, Reinhard; Gritsch, Herbert

Subjects: VON Willebrand factor; PATHOLOGICAL laboratories; VON Willebrand disease

• Source: Haemophilia; Jan2024, Vol. 30 Issue 1, p151-160, 10p

Record details

Surgery in mild haemophilia A patients with a history of inhibitor antibodies against factor VIII: Individualized management.

• Authors : Poon, Man‐Chiu^1,2,3,4 (AUTHOR) ; Goodyear, M. Dawn^1,4 (AUTHOR); Rydz, Natalia^1,4 (AUTHOR)

Subjects: *BLOOD coagulation factor VIII antibodies; *VON Willebrand disease; *IMMUNOADSORPTION

• Source: Haemophilia. Nov2021, Vol. 27 Issue 6, pe768-e771. 4p. 1 Chart.

Record details

Persistent inhibitor in acquired haemophilia A: A case for emicizumab?

• Authors : Ganslmeier, Mira^1,2 (AUTHOR); Pekrul, Isabell^1,2 (AUTHOR); Heinrich, Daniel Alexander³ (AUTHOR)

Subjects: *EMICIZUMAB; *BLOOD coagulation factor VIII antibodies; *VON Willebrand disease

• Source: Haemophilia. Jul2021, Vol. 27 Issue 4, pe502-e505. 4p. 2 Graphs.

Record details

In response to WFH guidelines for the management of haemophilia, 3rd edition: Is there a difference between extended‐half‐life FVIII products or not?

• Authors : Berntorp, Erik¹ (AUTHOR) ; Krassova, Snejana² (AUTHOR); Aledort, Louis³ (AUTHOR)

Subjects: *HEMOPHILIA; *BLOOD coagulation factor VIII; *VON Willebrand disease

• Source: Haemophilia. Nov2021, Vol. 27 Issue 6, pe762-e764. 3p. 1 Chart.

Record details

Recurrence of a high‐titre factor VIII inhibitor in a haemophilia A patient on emicizumab prophylaxis.

• Authors : Doshi, Bhavya S.^1,2 (AUTHOR) ; Witmer, Char M.^1,2 (AUTHOR)

Subjects: *BLOOD coagulation factor VIII antibodies; *EMICIZUMAB; *TITERS

• Source: Haemophilia. Jul2021, Vol. 27 Issue 4, pe551-e553. 3p. 1 Graph.

Record details